This page contains information about prescription medications. According to the Russian regulatory requirements, this information can be available only for medical or pharmaceutical stuff.

Do you confirm that you are a medical of pharmaceutical specialist?

Report an adverse reaction
Main pageOur products


Test systems for detecting antibodies to coronavirus SARS-CoV-2


Antigma® test systems are produced by GENERIUM in partnership with Medical and Biological Union LLC. They make it possible to determine with high reliability the level of “quick” response immunoglobulins, such as A (IgA) or M (IgM), as well as immunoglobulins indicating the formation of a persistent immune response G (IgG) using enzyme-linked immunosorbent assay (ELISA).

The Antigma-G® test system is intended for the quantitative detection of class G antibodies (IgG) to the SARS-CoV-2 virus. This test allows you to identify patients with immunity and assess the level of “herd” (population) immunity in society.

The Antigma-M test system is intended for the qualitative detection of class M antibodies (IgM) to the SARS-CoV-2 virus in human serum, blood plasma and capillary blood plasma.

Functional purpose: assessment of the immune response to a current infection (SARS-CoV-2 coronavirus).

The reagent kit is used to assess the extent of the spread of COVID-19.

Area of ​​application: clinical laboratory diagnostics. Instructions for use of the medical device "Antigma-M", Instructions for use of the medical device "Antigma-G".


A hotline has been set up for questions regarding testing.

Phone No.: 8 (495) 988-47-94

on technical characteristics and methodological features of the test system – dial ext. 7105

regarding the purchase of a test system – ext. 7060

on the diagnostic significance of the test system – ext. 7098